Exscientia PLCNASDAQ:EXAI
- LAST PRICE5.5200
- TODAY'S CHANGE (%)0.2200 (4.1509%)
- Bid / Lots5.5100/ 1
- Ask / Lots5.5300/ 11
- Open / Previous Close5.4000 / 5.3000
- Day Range
- 52 Week Range
- Volume390,918
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EXAI |
|---|---|---|
| 09:32 ET | 26807 | 5.39 |
| 09:34 ET | 3243 | 5.45 |
| 09:36 ET | 25009 | 5.53 |
| 09:38 ET | 3435 | 5.5033 |
| 09:39 ET | 3220 | 5.5 |
| 09:41 ET | 3766 | 5.48 |
| 09:43 ET | 3623 | 5.43 |
| 09:45 ET | 2578 | 5.45 |
| 09:48 ET | 1951 | 5.4 |
| 09:50 ET | 1573 | 5.41 |
| 09:52 ET | 350 | 5.43 |
| 09:54 ET | 2574 | 5.405 |
| 09:56 ET | 12410 | 5.35 |
| 09:57 ET | 23189 | 5.25 |
| 09:59 ET | 4123 | 5.27 |
| 10:01 ET | 1286 | 5.29 |
| 10:03 ET | 2462 | 5.3011 |
| 10:06 ET | 1924 | 5.3101 |
| 10:08 ET | 6391 | 5.3201 |
| 10:10 ET | 200 | 5.3596 |
| 10:12 ET | 950 | 5.36 |
| 10:15 ET | 4074 | 5.44 |
| 10:17 ET | 3740 | 5.43 |
| 10:19 ET | 1153 | 5.49 |
| 10:21 ET | 1400 | 5.5 |
| 10:24 ET | 3920 | 5.52 |
| 10:26 ET | 4089 | 5.53 |
| 10:28 ET | 5298 | 5.4648 |
| 10:30 ET | 1000 | 5.4701 |
| 10:32 ET | 5546 | 5.43 |
| 10:33 ET | 3800 | 5.4699 |
| 10:35 ET | 250 | 5.435 |
| 10:37 ET | 2100 | 5.435 |
| 10:39 ET | 11549 | 5.42 |
| 10:42 ET | 200 | 5.47 |
| 10:46 ET | 900 | 5.4208 |
| 10:51 ET | 1200 | 5.3931 |
| 10:53 ET | 6678 | 5.33 |
| 10:55 ET | 1145 | 5.32 |
| 11:02 ET | 1270 | 5.38 |
| 11:04 ET | 100 | 5.3971 |
| 11:06 ET | 475 | 5.39 |
| 11:08 ET | 965 | 5.3871 |
| 11:09 ET | 300 | 5.4 |
| 11:11 ET | 2700 | 5.4299 |
| 11:13 ET | 4226 | 5.4398 |
| 11:15 ET | 1377 | 5.4071 |
| 11:18 ET | 1025 | 5.415 |
| 11:20 ET | 460 | 5.415 |
| 11:22 ET | 5316 | 5.425 |
| 11:24 ET | 59117 | 5.505 |
| 11:26 ET | 12761 | 5.53 |
| 11:27 ET | 28955 | 5.5 |
| 11:29 ET | 22402 | 5.495 |
| 11:31 ET | 9658 | 5.498 |
| 11:33 ET | 10682 | 5.54 |
| 11:36 ET | 2934 | 5.5692 |
| 11:38 ET | 6692 | 5.53 |
| 11:40 ET | 6374 | 5.52 |
Today
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Exscientia p.l.c. of Class Action Lawsuit and Upcoming Deadlines - EXAI, from 31 minutes ago by Dow Jones
31 minutes ago by Dow JonesLost Money on Exscientia plc(EXAI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesLowey Dannenberg Notifies Exscientia p.l.c. ("Exscientia" or the "Company") (NASDAQ: EXAI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesEXAI LAWSUIT ALERT: Levi & Korsinsky Notifies Exscientia plc Investors of a Class Action Lawsuit and Upcoming Deadline, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesEXAI SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Exscientia p.l.c. Investors to Join the Class Action Lawsuit!, from 6 hours ago by Dow Jones
6 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Exscientia PLC | 459.6M | -4.2x | --- |
Cartesian Therapeutics Inc | 617.9M | -0.8x | --- |
OmniAb Inc | 510.5M | -6.8x | --- |
Arbutus Biopharma Corp | 634.1M | -7.7x | --- |
Iteos Therapeutics Inc | 604.7M | -4.5x | --- |
Taysha Gene Therapies Inc | 641.5M | -3.2x | --- |
Company Information
Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing, and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its precision medicine platform in oncology, while its partnered pipeline broadens its approach to other therapeutic areas. Its patient-first AI platform includes Patient-first AI, Precision Target, Precision Design, Precision Experiment, and Precision Medicine. Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. The Company’s advanced biophysical and x-ray techniques provide the ideal experimental underpinnings for AI-design.
Contact Information
- Headquarters
- The Schrodinger Building Oxford Science ParkOXFORD, United Kingdom OX4 4GE
- Phone
- 186-581-8941
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- David Nicholson
- Interim Chief Executive Officer, Chief Scientific Officer
- David Hallett
- Chief Financial and Strategy Officer, Director
- Ben Taylor
- Chief Technology Officer
- Garry Pairaudeau
- Chief Quantitative Medical Officer
- Michael Krams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $459.6M |
|---|---|
Revenue (TTM) | $25.0M |
Shares Outstanding | 86.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.30 |
Book Value | $3.61 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 18.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -802.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
